Drug intelligence / Profile preview

Standardized Mite, Mixed

Development stage
Unknown
Lead developer
Stallergenes Greer
Modality
Recombinant Proteins and Enzymes
Administration
Subcutaneous, Intradermal
01

Overview

Standardized Mite, Mixed (also known as mixed mite extract) is an allergenic extract biologic composed of equal parts of *Dermatophagoides farinae* and *Dermatophagoides pteronyssinus* allergen extracts. It is indicated for the diagnosis of dust mite hypersensitivity through skin testing and for allergen-specific immunotherapy (desensitization) to mitigate symptoms of mite-induced allergic rhinitis, allergic conjunctivitis, and allergic asthma. The product works by gradually desensitizing the patient's immune system to specific dust mite allergens, thereby reducing the IgE-mediated allergic response upon subsequent exposure. It is typically formulated as a sterile solution in 50% glycerin with phenol as a preservative and is administered via subcutaneous injection for immunotherapy or intradermal/prick testing for diagnosis.

Brand names
Standardized Mite, Mixed
Other names
mixed mite extractStandardized Mite Mixture ExtractDust mite allergen extractDermatophagoides farinae and Dermatophagoides pteronyssinus extract

Beyond the preview

Go deeper on Standardized Mite, Mixed.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Standardized Mite, Mixed.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call